Assenagon Asset Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-254,483
Closed -$7.09M 1431
2021
Q3
$7.09M Sell
254,483
-1,421
-0.6% -$40.3K 0.02% 343
2021
Q2
$7.5M Buy
255,904
+18,670
+8% +$566K 0.03% 398
2021
Q1
$7.53M Buy
+237,234
New +$6.96M 0.03% 405
2020
Q4
Sell
-762,349
Closed -$11.8M 1025
2020
Q3
$11.8M Sell
762,349
-455,752
-37% -$7.85M 0.07% 170
2020
Q2
$22.3M Buy
1,218,101
+761,617
+167% +$13.4M 0.14% 98
2020
Q1
$7.08M Buy
+456,484
New +$11M 0.06% 193
2019
Q2
Sell
-311,445
Closed -$7.69M 1008
2019
Q1
$7.69M Sell
311,445
-1,675
-0.5% -$40K 0.07% 231
2018
Q4
$5.78M Sell
313,120
-95,269
-23% -$2.27M 0.07% 215
2018
Q3
$10.5M Sell
408,389
-911,913
-69% -$20.9M 0.1% 180
2018
Q2
$30.7M Buy
+1,320,302
New +$27.3M 0.35% 80
2018
Q1
Sell
-525,673
Closed -$10.9M 555
2017
Q4
$10.9M Buy
+525,673
New +$8.34M 0.11% 167

Other funds holding BHC

Assenagon Asset Management's BHC Position: Q4 2021 in Review

Assenagon Asset Management sold out of Bausch Health (BHC) in Q4 2021, closing a stake of 254,483 shares — an estimated $7.09M sold.

Assenagon Asset Management first reported a position in BHC in Q4 2017 and held it in 11 quarters. The position peaked at $30.7M in Q2 2018. 377 funds tracked by Wall St. Rank hold BHC as of Q4 2021.

  • Assenagon Asset Management reported no remaining Bausch Health position as of Q4 2021 after selling out during the quarter.
  • Assenagon Asset Management sold 254,483 Bausch Health shares in Q4 2021, an estimated $7.09M.
  • Assenagon Asset Management first reported a position in Bausch Health in Q4 2017 and held it in 11 quarters.
  • Assenagon Asset Management's Bausch Health position peaked at $30.7M in Q2 2018.
  • 377 funds tracked by Wall St. Rank held Bausch Health as of Q4 2021.

Based on Assenagon Asset Management's 13F filing for Q4 2021, filed 1 Feb 2022.